Safety of linezolid in patients with decreased renal function and trough monitoring: a systematic review and meta-analysis

BACKGROUND: Linezolid causes hematological toxicity, mostly thrombocytopenia, which leads to treatment discontinuation and failure. Recent studies revealed that during linezolid therapy, the incidence of treatment-related hematological toxicity is significantly higher in patients with decreased rena...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoxi, Aoki, Mari, Osa, Sumika, Ito, Chihiro, Saiki, Reika, Nagai, Tomoya, Enoki, Yuki, Taguchi, Kazuaki, Matsumoto, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714190/
https://www.ncbi.nlm.nih.gov/pubmed/36451204
http://dx.doi.org/10.1186/s40360-022-00628-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714190/
https://www.ncbi.nlm.nih.gov/pubmed/36451204
http://dx.doi.org/10.1186/s40360-022-00628-9

Ejemplares similares